Skip to main content
Caplight Logo









Novaptech

Novaptech

Private
GradignanHealthcare & Life Scienceshttps://novaptech.com/en/

Last Round

Early Funding

Feb 1, 2019

Total Funding Raised

$530,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Novaptech is a biotechnology company that provides custom aptamer development services for diagnostics and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

aptamerscontract research organizationCROaptamer discoveryantibody alternativessynthetic antibodiesSELEXaptamer-based assaysynthetic oligonucleotidesNOVAswitchdiagnostic kitsdrug discoverysmall molecule bindingenvironmental monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novaptech Comparables

Compare Novaptech with similar companies based on industry and business-model similarity.

Novaptech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Base Pair Biotechnologies
92%
Aptagen, LLC
88%
NeoVentures Biotechnology Inc.
86%

Novaptech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 1, 2019
SeedJan 24, 2017

Key People

Founding team and executive leadership

Alice Piters

Directrice Technique (CTO)

Executive Team

Novaptech Investors

Notable investors and investment history

Novaptech investors
InvestorRounds
UnitecSeed
Aquiti GestionEarly Funding, Seed
Région Nouvelle-AquitaineGrant, Seed
Aquitaine Science TransfertSeed
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 1722% MoM, from 37 to 674.

  • Jan 27, 2026

    Monthly visitors grew 126% MoM, reaching 1K.

Novaptech Filings

Explore SEC and related filing metadata, where available.

Novaptech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novaptech's valuation, stock price, and market status.

Is Novaptech a public or private company?

Novaptech is a private company.

What is the current stock price of Novaptech?

Novaptech is a private company with no public stock price. No recent secondary market data is available.

How much is Novaptech worth (valuation)?

Valuation information for Novaptech is not publicly available.

Can I buy Novaptech stock?

Novaptech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novaptech's last funding round?

Funding round information for Novaptech is not publicly available.

Who are the main investors in Novaptech?

Investor information for Novaptech is not publicly disclosed.

Will Novaptech IPO soon?

No public IPO plans have been announced for Novaptech.

How can I track Novaptech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novaptech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGradignan
Employee Range11
Year Founded2016
Last FundingFeb 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?